机构:[a]Fu-Xing Hospital,[b]Xuanwu Hospital,首都医科大学宣武医院[c]Beijing Friendship Hospital, Capital Medical College,首都医科大学附属北京友谊医院[d]The 309th MilitaryHospital of Chinese People’s Liberation Army, affiliated to Capital Medical College,[e]Beijing Chao-Yang Hospital,北京朝阳医院[f]First Affiliated Hospital of PLA General Hospital,[g]Beijing Chuiyangliu Hospital,[h]Beijing Tsinghua ChanggungHospital,[i]Beijing Hospital,[j]Beijing Tongren Hospital,首都医科大学附属北京同仁医院首都医科大学附属同仁医院[k]Chinese People’s Liberation Army Rocket Army Hospital, l PLAArmy General Hospital,[m]Beijing Aerospace Center Hospital,[n]Peking Union Medical College Hospital, Beijing ,China
第一作者机构:[n]Peking Union Medical College Hospital, Beijing ,China
通讯作者:
通讯机构:[n]Peking Union Medical College Hospital, Beijing ,China[*1]Department of Hematology Peking Union Medical College Hospital, No. 1 Shuaifuyuan Dongcheng District, Beijing 100730 (China)
推荐引用方式(GB/T 7714):
Hongmin Li,Liru Wang,Yue Wu,et al.VERY LOW-DOSE DECITABINE IS EFFECTIVE IN TREATING INTERMEDIATE OR HIGH RISK MYELODYSPLASTIC SYNDROME[J].LEUKEMIA RESEARCH.2017,55:S65-S66.doi:10.1016/S0145-2126(17)30218-7.
APA:
Hongmin Li,Liru Wang,Yue Wu,Li Su,Hong Zhao...&Bing Han.(2017).VERY LOW-DOSE DECITABINE IS EFFECTIVE IN TREATING INTERMEDIATE OR HIGH RISK MYELODYSPLASTIC SYNDROME.LEUKEMIA RESEARCH,55,
MLA:
Hongmin Li,et al."VERY LOW-DOSE DECITABINE IS EFFECTIVE IN TREATING INTERMEDIATE OR HIGH RISK MYELODYSPLASTIC SYNDROME".LEUKEMIA RESEARCH 55.(2017):S65-S66